Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder
A six- to eight-week double-blind placebo-controlled trial of the potent and selective serotonin reuptake inhibitor fluvoxamine was conducted in 42 patients with primary obsessi...
Publications
4 shownTreatment of severe obsessive-compulsive disorder with fluvoxamine
Ten obsessive-compulsive patients received single-blind treatment with fluvoxamine, a selective serotonin reuptake inhibitor, for several weeks following at least 2 weeks of pla...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 951
- Institution
- Yale University
External Links
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.